• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.刺突依赖性 SARS-CoV-2 致病性与 TMPRSS2 相关。
J Med Virol. 2021 Jul;93(7):4205-4218. doi: 10.1002/jmv.26911. Epub 2021 Mar 18.
2
The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.TMPRSS2 抑制剂那法莫司他可降低 COVID-19 小鼠模型中的 SARS-CoV-2 肺部感染。
mBio. 2021 Aug 31;12(4):e0097021. doi: 10.1128/mBio.00970-21. Epub 2021 Aug 3.
3
Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges.靶向肠道 TMPRSS2 蛋白酶以阻止 SARS-CoV-2 进入肠上皮细胞——前景与挑战。
Mol Biol Rep. 2021 May;48(5):4667-4675. doi: 10.1007/s11033-021-06390-1. Epub 2021 May 22.
4
The Transmembrane Protease Serine 2 (TMPRSS2) Non-Protease Domains Regulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike-Mediated Virus Entry.跨膜丝氨酸蛋白酶 2(TMPRSS2)非蛋白酶结构域调节严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突介导的病毒进入。
Viruses. 2023 Oct 19;15(10):2124. doi: 10.3390/v15102124.
5
Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.抑肽酶对TMPRSS2相关丝氨酸蛋白酶共价抑制机制的结构基础
J Virol. 2021 Sep 9;95(19):e0086121. doi: 10.1128/JVI.00861-21. Epub 2021 Jun 23.
6
Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.针对 SARS-CoV-2 的病毒进入促进剂作为 COVID-19 的治疗策略。
J Med Virol. 2021 Sep;93(9):5260-5276. doi: 10.1002/jmv.27019. Epub 2021 May 3.
7
Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2.羟氯喹通过抑制 TMPRSS2 来抑制 SARS-CoV-2 的进入。
PLoS Pathog. 2021 Jan 19;17(1):e1009212. doi: 10.1371/journal.ppat.1009212. eCollection 2021 Jan.
8
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.弗林蛋白酶和 TMPRSS2 在 SARS-CoV-2 感染中的独特作用。
J Virol. 2022 Apr 27;96(8):e0012822. doi: 10.1128/jvi.00128-22. Epub 2022 Mar 28.
9
D. Don Inhibits the Main Proteases (M and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.D.唐抑制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的主要蛋白酶(M和跨膜丝氨酸蛋白酶2(TMPRSS2))。
Viruses. 2021 May 2;13(5):826. doi: 10.3390/v13050826.
10
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.

引用本文的文献

1
Soybean Trypsin Inhibitor Possesses Potency Against SARS-CoV-2 Infection by Blocking the Host Cell Surface Receptors ACE2, TMPRSS2, and CD147.大豆胰蛋白酶抑制剂通过阻断宿主细胞表面受体ACE2、TMPRSS2和CD147对SARS-CoV-2感染具有抑制作用。
Int J Mol Sci. 2025 Jul 9;26(14):6583. doi: 10.3390/ijms26146583.
2
Insight into Covid Associated Mucormycosis: A Prospective Study.新型冠状病毒肺炎相关毛霉病的洞察:一项前瞻性研究。
Iran J Otorhinolaryngol. 2025;37(1):27-32. doi: 10.22038/ijorl.2024.78990.3662.
3
Down syndrome frontal cortex layer III and layer V pyramidal neurons exhibit lamina specific degeneration in aged individuals.唐氏综合征患者大脑前额皮质第三层和第五层的锥体细胞在老年人群中出现特定层的退化。
Acta Neuropathol Commun. 2024 Nov 27;12(1):182. doi: 10.1186/s40478-024-01891-z.
4
Analysis of microisolated frontal cortex excitatory layer III and V pyramidal neurons reveals a neurodegenerative phenotype in individuals with Down syndrome.分析微分离额皮质兴奋性第 III 和第 V 层的锥体神经元,揭示唐氏综合征个体存在神经退行性表型。
Acta Neuropathol. 2024 Aug 6;148(1):16. doi: 10.1007/s00401-024-02768-0.
5
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids.在K18-hACE2小鼠和人脑类器官中,SARS-CoV-2奥密克戎BA.5和XBB变体比BA.1具有更强的嗜神经性。
Front Microbiol. 2023 Nov 23;14:1320856. doi: 10.3389/fmicb.2023.1320856. eCollection 2023.
6
Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms.新型冠状病毒 2 在大脑中的长期影响:临床后果与分子机制
J Clin Med. 2023 Apr 28;12(9):3190. doi: 10.3390/jcm12093190.
7
COVID-19: The Ethno-Geographic Perspective of Differential Immunity.新冠病毒病(COVID-19):不同免疫的种族地理视角
Vaccines (Basel). 2023 Jan 31;11(2):319. doi: 10.3390/vaccines11020319.
8
Protease-Responsive Potential-Tunable AIEgens for Cell Selective Imaging of TMPRSS2 and Accurate Inhibitor Screening.蛋白酶响应型潜力可调 AIE gens 用于 TMPRSS2 的细胞选择性成像和准确抑制剂筛选。
Anal Chem. 2023 Feb 21;95(7):3789-3798. doi: 10.1021/acs.analchem.2c04988. Epub 2023 Feb 8.
9
Small molecules in the treatment of COVID-19.小分子药物治疗 COVID-19。
Signal Transduct Target Ther. 2022 Dec 5;7(1):387. doi: 10.1038/s41392-022-01249-8.
10
Impact of Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2.表达、突变预后以及小分子(CD、AD、TQ 和 TQFL12)抑制对泛癌肿瘤的影响和对 SARS-CoV-2 的易感性。
Molecules. 2022 Nov 1;27(21):7413. doi: 10.3390/molecules27217413.

本文引用的文献

1
Structural insights and inhibition mechanism of TMPRSS2 by experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-coronavirus-2: A molecular modeling approach.通过实验已知的抑制剂甲磺酸卡莫司他、那法莫司他和盐酸溴己新控制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)时TMPRSS2的结构见解和抑制机制:一种分子建模方法
Inform Med Unlocked. 2021;24:100597. doi: 10.1016/j.imu.2021.100597. Epub 2021 May 26.
2
Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes.雄激素对肺内 AR、TMPRSS2 和 ACE2 的调节作用及其对性别差异 COVID-19 结局的影响。
Sci Rep. 2021 May 27;11(1):11130. doi: 10.1038/s41598-021-90491-1.
3
Predicting the animal hosts of coronaviruses from compositional biases of spike protein and whole genome sequences through machine learning.通过机器学习从刺突蛋白和全基因组序列的组成偏差预测冠状病毒的动物宿主。
PLoS Pathog. 2021 Apr 20;17(4):e1009149. doi: 10.1371/journal.ppat.1009149. eCollection 2021 Apr.
4
Chopping the tail: How preventing superspreading can help to maintain COVID-19 control.斩断传播链:如何防止超级传播以帮助维持新冠疫情控制。
Epidemics. 2021 Mar;34:100430. doi: 10.1016/j.epidem.2020.100430. Epub 2020 Dec 21.
5
Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection.联合靶向 TMPRSS2 和组织蛋白酶 B/L 可能对 SARS-CoV-2 感染具有协同作用。
PLoS Comput Biol. 2020 Dec 8;16(12):e1008461. doi: 10.1371/journal.pcbi.1008461. eCollection 2020 Dec.
6
The impact of lockdown strategies targeting age groups on the burden of COVID-19 in France.针对年龄组的封锁策略对法国 COVID-19 负担的影响。
Epidemics. 2020 Dec;33:100424. doi: 10.1016/j.epidem.2020.100424. Epub 2020 Nov 24.
7
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2's main protease.分析 HIV 蛋白酶抑制剂对 SARS-CoV-2 主蛋白酶的疗效。
Virol J. 2020 Nov 26;17(1):190. doi: 10.1186/s12985-020-01457-0.
8
Pseudo-likelihood based logistic regression for estimating COVID-19 infection and case fatality rates by gender, race, and age in California.基于伪似然的逻辑回归估计加利福尼亚州按性别、种族和年龄划分的 COVID-19 感染率和病死率。
Epidemics. 2020 Dec;33:100418. doi: 10.1016/j.epidem.2020.100418. Epub 2020 Nov 9.
9
Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium.年龄相关的启动蛋白酶 TMPRSS2 的表达和 SARS-CoV-2 在肺上皮细胞中的定位。
J Clin Invest. 2021 Jan 4;131(1). doi: 10.1172/JCI140766.
10
Emergence of zoonoses such as COVID-19 reveals the need for health sciences to embrace an explicit eco-social conceptual framework of health and disease.人畜共患病(如 COVID-19)的出现表明,卫生科学需要采用明确的生态社会健康和疾病概念框架。
Epidemics. 2020 Dec;33:100410. doi: 10.1016/j.epidem.2020.100410. Epub 2020 Oct 21.

刺突依赖性 SARS-CoV-2 致病性与 TMPRSS2 相关。

Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.

机构信息

PsiMega2 (Pvt.) Ltd., Islamabad, Pakistan.

School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.

出版信息

J Med Virol. 2021 Jul;93(7):4205-4218. doi: 10.1002/jmv.26911. Epub 2021 Mar 18.

DOI:10.1002/jmv.26911
PMID:33638460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8014076/
Abstract

Epidemiological data shows a discrepancy in COVID-19 susceptibility and outcomes with some regions being more heavily affected than others. However, the factors that determine host susceptibility and pathogenicity remain elusive. An increasing number of publications highlight the role of Transmembrane Serine Protease 2 (TMPRSS2) in the susceptibility of the host cell to SARS-CoV-2. Cleavage of viral spike protein via the host cell's TMPRSS2 enzyme activity mediates viral entry into the host cell. The enzyme synthesis is regulated by the TMPRSS2 gene, which has also been implicated in the entry mechanisms of previously reported Coronavirus infections. In this review, we have investigated the pathogenicity of SARS-CoV-2 and disease susceptibility dependence on the TMPRSS2 gene as expressed in various population groups. We further discuss how the differential expression of this gene in various ethnic groups can affect the SARS-CoV-2 infection and Coronavirus disease (COVID)-19 outcomes. Moreover, promising new TMPRSS2 protease blockers and inhibitors are discussed for COVID-19 treatment.

摘要

流行病学数据显示,COVID-19 在不同地区的易感性和结果存在差异,有些地区比其他地区受到的影响更严重。然而,决定宿主易感性和致病性的因素仍然难以确定。越来越多的出版物强调了跨膜丝氨酸蛋白酶 2(TMPRSS2)在宿主细胞对 SARS-CoV-2 的易感性中的作用。通过宿主细胞的 TMPRSS2 酶活性切割病毒刺突蛋白,介导病毒进入宿主细胞。该酶的合成受 TMPRSS2 基因调控,该基因也与先前报道的冠状病毒感染的进入机制有关。在这篇综述中,我们研究了 SARS-CoV-2 的致病性以及宿主对 TMPRSS2 基因的易感性依赖性,该基因在不同人群中表达。我们进一步讨论了该基因在不同种族群体中的差异表达如何影响 SARS-CoV-2 感染和冠状病毒病(COVID-19)的结果。此外,还讨论了有前途的新型 TMPRSS2 蛋白酶阻滞剂和抑制剂在 COVID-19 治疗中的应用。